InsidersTradesSigma
Explore the full record of transactions filed by Karin Maria Botha, Chief Financial Officer. Officer active across 2 companies, notably Guard Therapeutics International AB (publ). Aggregated, 2 reports have been logged. Activity tracked since 3 April 2025. The latest transaction was disclosed on 15 May 2025 (Purchase). Regulator: FIN-FSA. The full history is openly available.
2 of 2 declarations
Karin Maria Botha is the Chief Financial Officer of Guard Therapeutics International AB (publ), a biopharmaceutical company. In her role, she is responsible for financial management and the company's financial strategy. Karin has a strong background in the sector, enabling her to contribute effectively to the growth and sustainability of Guard Therapeutics. Her financial expertise is essential to support the company's strategic objectives.